Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myelodysplastic Syndromes | 20 | 2023 | 1352 | 3.630 |
Why?
|
Leukemia, Myeloid, Acute | 20 | 2024 | 3524 | 2.110 |
Why?
|
Hematopoiesis | 9 | 2021 | 2073 | 1.280 |
Why?
|
Hematologic Neoplasms | 9 | 2021 | 1832 | 1.160 |
Why?
|
Hematopoietic Stem Cell Transplantation | 13 | 2024 | 5445 | 1.120 |
Why?
|
Mutation | 28 | 2023 | 29786 | 0.850 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 2022 | 188 | 0.790 |
Why?
|
Leukemia | 4 | 2022 | 1510 | 0.790 |
Why?
|
Bone Marrow Diseases | 3 | 2021 | 231 | 0.740 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 2 | 2022 | 294 | 0.740 |
Why?
|
Dioxygenases | 2 | 2021 | 316 | 0.740 |
Why?
|
Hemoglobinuria, Paroxysmal | 2 | 2018 | 102 | 0.710 |
Why?
|
Transplantation Conditioning | 7 | 2024 | 1599 | 0.700 |
Why?
|
Telomerase | 2 | 2021 | 730 | 0.680 |
Why?
|
Anemia, Aplastic | 2 | 2018 | 226 | 0.650 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2022 | 670 | 0.620 |
Why?
|
Pancytopenia | 1 | 2017 | 104 | 0.560 |
Why?
|
Myeloproliferative Disorders | 5 | 2024 | 606 | 0.530 |
Why?
|
Telomere | 2 | 2020 | 910 | 0.520 |
Why?
|
Disease Susceptibility | 3 | 2023 | 1782 | 0.520 |
Why?
|
Clone Cells | 3 | 2017 | 1692 | 0.510 |
Why?
|
Neoplasms, Second Primary | 3 | 2024 | 1062 | 0.500 |
Why?
|
Neoplasm, Residual | 2 | 2022 | 973 | 0.470 |
Why?
|
Hematopoietic Stem Cells | 6 | 2020 | 3390 | 0.460 |
Why?
|
Hematologic Diseases | 1 | 2017 | 498 | 0.440 |
Why?
|
Bone Marrow Neoplasms | 1 | 2013 | 104 | 0.430 |
Why?
|
Proto-Oncogene Proteins c-cbl | 1 | 2012 | 119 | 0.410 |
Why?
|
Stem Cell Transplantation | 1 | 2020 | 1620 | 0.410 |
Why?
|
Transplantation, Homologous | 9 | 2024 | 4777 | 0.400 |
Why?
|
B-Lymphocyte Subsets | 5 | 2019 | 246 | 0.390 |
Why?
|
Leukemia, Erythroblastic, Acute | 2 | 2021 | 189 | 0.350 |
Why?
|
Tumor Suppressor Protein p53 | 6 | 2023 | 2949 | 0.340 |
Why?
|
Embryonic Stem Cells | 3 | 2011 | 1295 | 0.300 |
Why?
|
Repressor Proteins | 5 | 2022 | 3024 | 0.300 |
Why?
|
Sulfonamides | 4 | 2024 | 1940 | 0.290 |
Why?
|
Bone Marrow | 6 | 2023 | 2948 | 0.290 |
Why?
|
DNA-Binding Proteins | 3 | 2021 | 9647 | 0.290 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2012 | 988 | 0.280 |
Why?
|
Graft vs Host Disease | 3 | 2024 | 2958 | 0.280 |
Why?
|
Survival Rate | 5 | 2021 | 12788 | 0.280 |
Why?
|
Genetic Variation | 1 | 2021 | 6542 | 0.270 |
Why?
|
Wnt Proteins | 2 | 2008 | 721 | 0.270 |
Why?
|
Lymphoma, B-Cell | 1 | 2012 | 931 | 0.260 |
Why?
|
Cytarabine | 3 | 2024 | 692 | 0.260 |
Why?
|
Epigenesis, Genetic | 5 | 2022 | 3646 | 0.260 |
Why?
|
Postoperative Hemorrhage | 1 | 2008 | 412 | 0.250 |
Why?
|
ras Proteins | 2 | 2022 | 1060 | 0.250 |
Why?
|
fms-Like Tyrosine Kinase 3 | 4 | 2023 | 491 | 0.250 |
Why?
|
Alleles | 5 | 2022 | 6933 | 0.240 |
Why?
|
Blood Loss, Surgical | 1 | 2008 | 662 | 0.240 |
Why?
|
Recombinant Fusion Proteins | 2 | 2012 | 3773 | 0.240 |
Why?
|
Humans | 65 | 2024 | 744366 | 0.230 |
Why?
|
Gene Duplication | 2 | 2022 | 329 | 0.230 |
Why?
|
Mesoderm | 1 | 2006 | 686 | 0.220 |
Why?
|
Hand | 1 | 2008 | 884 | 0.220 |
Why?
|
Anthracyclines | 2 | 2023 | 288 | 0.220 |
Why?
|
RNA Splice Sites | 1 | 2023 | 209 | 0.210 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2008 | 1115 | 0.210 |
Why?
|
DNA Damage | 2 | 2023 | 2432 | 0.210 |
Why?
|
Gene Expression Regulation, Developmental | 3 | 2011 | 3617 | 0.210 |
Why?
|
Tandem Repeat Sequences | 2 | 2020 | 185 | 0.200 |
Why?
|
Thrombocytopenia | 2 | 2023 | 1178 | 0.200 |
Why?
|
Genetic Predisposition to Disease | 4 | 2022 | 17446 | 0.200 |
Why?
|
Disease-Free Survival | 3 | 2021 | 6896 | 0.200 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2023 | 222 | 0.200 |
Why?
|
Cell Cycle Proteins | 3 | 2022 | 3464 | 0.200 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2020 | 3595 | 0.200 |
Why?
|
Erythropoiesis | 2 | 2016 | 706 | 0.200 |
Why?
|
Cell Differentiation | 10 | 2019 | 11486 | 0.190 |
Why?
|
Eukaryotic Initiation Factors | 1 | 2021 | 92 | 0.190 |
Why?
|
Hydroxyurea | 1 | 2022 | 289 | 0.190 |
Why?
|
Cardiovascular System | 1 | 2008 | 831 | 0.190 |
Why?
|
Stem Cells | 3 | 2020 | 3567 | 0.190 |
Why?
|
Embryo, Mammalian | 1 | 2006 | 1701 | 0.180 |
Why?
|
DNA Mutational Analysis | 4 | 2017 | 4185 | 0.180 |
Why?
|
Dyskeratosis Congenita | 1 | 2020 | 72 | 0.170 |
Why?
|
Prognosis | 9 | 2023 | 29060 | 0.170 |
Why?
|
Mutation, Missense | 3 | 2019 | 2566 | 0.170 |
Why?
|
Melphalan | 1 | 2020 | 431 | 0.170 |
Why?
|
Mycoses | 1 | 2022 | 376 | 0.160 |
Why?
|
Point Mutation | 2 | 2015 | 1624 | 0.160 |
Why?
|
Candidiasis | 1 | 2021 | 366 | 0.160 |
Why?
|
Janus Kinase 2 | 2 | 2022 | 528 | 0.160 |
Why?
|
Proto-Oncogene Proteins | 3 | 2022 | 4554 | 0.150 |
Why?
|
Recurrence | 4 | 2022 | 8340 | 0.150 |
Why?
|
Mesenchymal Stem Cells | 1 | 2008 | 1632 | 0.150 |
Why?
|
Ribosomes | 1 | 2021 | 500 | 0.150 |
Why?
|
Azepines | 1 | 2019 | 334 | 0.150 |
Why?
|
Adult | 17 | 2023 | 214052 | 0.140 |
Why?
|
Neoplasms | 5 | 2023 | 21696 | 0.140 |
Why?
|
Germ-Line Mutation | 2 | 2022 | 1788 | 0.140 |
Why?
|
Leukopenia | 1 | 2017 | 213 | 0.140 |
Why?
|
B-Lymphocytes | 2 | 2006 | 4666 | 0.140 |
Why?
|
Epithelial Cells | 1 | 2008 | 3690 | 0.140 |
Why?
|
Young Adult | 8 | 2021 | 56429 | 0.130 |
Why?
|
Calgranulin A | 1 | 2016 | 79 | 0.130 |
Why?
|
Calgranulin B | 1 | 2016 | 84 | 0.130 |
Why?
|
Anemia, Dyserythropoietic, Congenital | 1 | 2015 | 15 | 0.130 |
Why?
|
Leukemia, Mast-Cell | 1 | 2015 | 14 | 0.130 |
Why?
|
Ribonucleoprotein, U2 Small Nuclear | 1 | 2014 | 21 | 0.130 |
Why?
|
Interleukin-2 | 1 | 2022 | 1904 | 0.130 |
Why?
|
Anemia, Macrocytic | 1 | 2015 | 55 | 0.130 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2020 | 719 | 0.130 |
Why?
|
5-Aminolevulinate Synthetase | 1 | 2015 | 57 | 0.130 |
Why?
|
RNA | 2 | 2022 | 2749 | 0.130 |
Why?
|
Cancer Vaccines | 1 | 2022 | 1023 | 0.120 |
Why?
|
RNA Splicing | 2 | 2023 | 908 | 0.120 |
Why?
|
Selection, Genetic | 1 | 2019 | 914 | 0.120 |
Why?
|
Genes, p53 | 1 | 2017 | 755 | 0.120 |
Why?
|
Antigens, Nuclear | 1 | 2014 | 192 | 0.120 |
Why?
|
Haploinsufficiency | 1 | 2016 | 328 | 0.120 |
Why?
|
Middle Aged | 14 | 2023 | 213390 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2015 | 318 | 0.120 |
Why?
|
HLA Antigens | 1 | 2019 | 1382 | 0.120 |
Why?
|
Ribosomal Proteins | 1 | 2016 | 360 | 0.120 |
Why?
|
Adolescent | 7 | 2021 | 85779 | 0.110 |
Why?
|
Mice | 19 | 2023 | 81201 | 0.110 |
Why?
|
Anemia, Sickle Cell | 1 | 2021 | 1020 | 0.110 |
Why?
|
Mastocytosis, Systemic | 1 | 2015 | 100 | 0.110 |
Why?
|
Animals | 21 | 2023 | 168768 | 0.110 |
Why?
|
Anticoagulants | 1 | 2008 | 4600 | 0.110 |
Why?
|
Medical Informatics | 1 | 2020 | 745 | 0.110 |
Why?
|
Gene Rearrangement, B-Lymphocyte | 1 | 2012 | 111 | 0.100 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2023 | 2073 | 0.100 |
Why?
|
Blood | 1 | 2014 | 598 | 0.100 |
Why?
|
Hemorrhage | 2 | 2022 | 3461 | 0.100 |
Why?
|
Models, Immunological | 2 | 2005 | 527 | 0.100 |
Why?
|
Ribonucleoproteins | 1 | 2014 | 381 | 0.100 |
Why?
|
Germ Layers | 1 | 2011 | 73 | 0.100 |
Why?
|
Gene Deletion | 1 | 2019 | 2751 | 0.100 |
Why?
|
Phosphoproteins | 2 | 2023 | 2441 | 0.100 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2015 | 372 | 0.100 |
Why?
|
Infant | 3 | 2021 | 35134 | 0.090 |
Why?
|
Genetic Markers | 1 | 2017 | 2634 | 0.090 |
Why?
|
Receptors, Complement | 3 | 2006 | 264 | 0.090 |
Why?
|
Aged | 11 | 2023 | 163288 | 0.090 |
Why?
|
Cell Dedifferentiation | 1 | 2011 | 135 | 0.090 |
Why?
|
Male | 14 | 2021 | 350115 | 0.090 |
Why?
|
Chromatin | 1 | 2022 | 2933 | 0.090 |
Why?
|
Leukemia, Myeloid | 1 | 2013 | 707 | 0.090 |
Why?
|
Female | 16 | 2023 | 380193 | 0.090 |
Why?
|
Child, Preschool | 3 | 2021 | 41005 | 0.090 |
Why?
|
Myeloid Cells | 1 | 2015 | 810 | 0.090 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 1520 | 0.090 |
Why?
|
Transplantation, Autologous | 3 | 2024 | 2124 | 0.090 |
Why?
|
Hospitals | 1 | 2023 | 3954 | 0.090 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2011 | 713 | 0.090 |
Why?
|
Phenotype | 2 | 2020 | 16367 | 0.090 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2017 | 1381 | 0.090 |
Why?
|
Remission Induction | 1 | 2014 | 2385 | 0.080 |
Why?
|
Genomic Instability | 1 | 2013 | 695 | 0.080 |
Why?
|
B-Cell Activating Factor | 2 | 2006 | 119 | 0.080 |
Why?
|
Cytokines | 2 | 2021 | 7323 | 0.080 |
Why?
|
Hodgkin Disease | 1 | 2017 | 1415 | 0.080 |
Why?
|
Child | 4 | 2021 | 77709 | 0.080 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2020 | 1736 | 0.080 |
Why?
|
Membrane Glycoproteins | 3 | 2006 | 3771 | 0.080 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2013 | 735 | 0.080 |
Why?
|
Spleen | 2 | 2006 | 2362 | 0.080 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 2 | 2011 | 547 | 0.080 |
Why?
|
Tissue Donors | 1 | 2017 | 2241 | 0.080 |
Why?
|
Pyrimidines | 1 | 2019 | 2943 | 0.080 |
Why?
|
Histones | 2 | 2019 | 2598 | 0.080 |
Why?
|
Diagnosis, Differential | 2 | 2020 | 12961 | 0.070 |
Why?
|
Mast Cells | 1 | 2015 | 1544 | 0.070 |
Why?
|
Receptors, IgE | 2 | 2006 | 389 | 0.070 |
Why?
|
Transcription Factors | 4 | 2022 | 12207 | 0.070 |
Why?
|
Signal Transduction | 3 | 2022 | 23404 | 0.070 |
Why?
|
Doxycycline | 1 | 2008 | 326 | 0.070 |
Why?
|
Antifungal Agents | 2 | 2022 | 729 | 0.070 |
Why?
|
Graft Survival | 1 | 2017 | 3737 | 0.070 |
Why?
|
Chronic Disease | 1 | 2021 | 9145 | 0.070 |
Why?
|
Mice, Knockout | 5 | 2019 | 14561 | 0.070 |
Why?
|
L-Selectin | 1 | 2006 | 214 | 0.070 |
Why?
|
Anemia | 1 | 2016 | 1503 | 0.070 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2024 | 1692 | 0.070 |
Why?
|
Sequence Analysis, DNA | 1 | 2017 | 4805 | 0.070 |
Why?
|
RNA-Binding Proteins | 1 | 2015 | 1903 | 0.070 |
Why?
|
Disease Progression | 1 | 2022 | 13286 | 0.070 |
Why?
|
MicroRNAs | 2 | 2011 | 3751 | 0.060 |
Why?
|
Receptors, Tumor Necrosis Factor | 2 | 2004 | 595 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 15078 | 0.060 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2014 | 2943 | 0.060 |
Why?
|
Genes, Dominant | 2 | 2019 | 880 | 0.060 |
Why?
|
Genomics | 4 | 2023 | 5717 | 0.060 |
Why?
|
Antineoplastic Agents | 2 | 2021 | 13693 | 0.060 |
Why?
|
Daunorubicin | 1 | 2024 | 158 | 0.060 |
Why?
|
Nuclear Proteins | 2 | 2019 | 5856 | 0.060 |
Why?
|
Cell Survival | 3 | 2016 | 5882 | 0.060 |
Why?
|
DNA Methylation | 2 | 2019 | 4285 | 0.060 |
Why?
|
Survival Analysis | 1 | 2017 | 10252 | 0.060 |
Why?
|
Retrospective Studies | 5 | 2024 | 77460 | 0.060 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2008 | 455 | 0.060 |
Why?
|
Interleukin-4 | 1 | 2006 | 1147 | 0.060 |
Why?
|
Flow Cytometry | 4 | 2016 | 5974 | 0.050 |
Why?
|
Cells, Cultured | 5 | 2015 | 19233 | 0.050 |
Why?
|
Lymphoid Tissue | 1 | 2004 | 455 | 0.050 |
Why?
|
Blotting, Western | 3 | 2016 | 5181 | 0.050 |
Why?
|
Azacitidine | 1 | 2024 | 347 | 0.050 |
Why?
|
Ligands | 2 | 2006 | 3282 | 0.050 |
Why?
|
Guanosine Triphosphate | 1 | 2022 | 321 | 0.050 |
Why?
|
Vaccines, Subunit | 1 | 2022 | 168 | 0.050 |
Why?
|
Exons | 2 | 2020 | 2439 | 0.050 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2023 | 431 | 0.050 |
Why?
|
Proteins | 1 | 2017 | 6100 | 0.050 |
Why?
|
Cullin Proteins | 1 | 2022 | 181 | 0.050 |
Why?
|
Sequence Analysis, RNA | 2 | 2023 | 2012 | 0.050 |
Why?
|
Calreticulin | 1 | 2022 | 98 | 0.050 |
Why?
|
Apoptosis | 2 | 2016 | 9724 | 0.050 |
Why?
|
Gene Frequency | 2 | 2020 | 3587 | 0.050 |
Why?
|
Receptors, Virus | 1 | 2004 | 649 | 0.050 |
Why?
|
beta Catenin | 1 | 2006 | 1059 | 0.050 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2006 | 838 | 0.050 |
Why?
|
Busulfan | 1 | 2021 | 263 | 0.050 |
Why?
|
Perioperative Care | 1 | 2008 | 1002 | 0.050 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2004 | 548 | 0.050 |
Why?
|
Administration, Oral | 1 | 2008 | 3914 | 0.050 |
Why?
|
GATA2 Transcription Factor | 1 | 2021 | 161 | 0.050 |
Why?
|
Vidarabine | 1 | 2021 | 345 | 0.050 |
Why?
|
Idarubicin | 1 | 2019 | 62 | 0.050 |
Why?
|
Neoplasm Staging | 1 | 2014 | 11031 | 0.050 |
Why?
|
Time Factors | 1 | 2021 | 40075 | 0.040 |
Why?
|
Algorithms | 1 | 2020 | 13882 | 0.040 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2006 | 2455 | 0.040 |
Why?
|
Molecular Biology | 1 | 2023 | 596 | 0.040 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2023 | 692 | 0.040 |
Why?
|
Genes, Reporter | 2 | 2015 | 1547 | 0.040 |
Why?
|
Major Histocompatibility Complex | 1 | 2022 | 936 | 0.040 |
Why?
|
Bone Marrow Cells | 2 | 2004 | 2513 | 0.040 |
Why?
|
Kinetics | 1 | 2006 | 6476 | 0.040 |
Why?
|
Endothelial Cells | 1 | 2011 | 3486 | 0.040 |
Why?
|
Germ Cells | 1 | 2022 | 631 | 0.040 |
Why?
|
Precursor Cells, B-Lymphoid | 1 | 2019 | 98 | 0.040 |
Why?
|
Receptors, Immunologic | 1 | 2004 | 1423 | 0.040 |
Why?
|
Protein Isoforms | 1 | 2023 | 1730 | 0.040 |
Why?
|
Mice, Inbred C57BL | 4 | 2022 | 21833 | 0.040 |
Why?
|
Nuclear Pore Complex Proteins | 1 | 2019 | 165 | 0.040 |
Why?
|
Genome-Wide Association Study | 1 | 2017 | 12262 | 0.040 |
Why?
|
Janus Kinases | 1 | 2019 | 244 | 0.040 |
Why?
|
Cytosine | 1 | 2019 | 216 | 0.040 |
Why?
|
Interferon-alpha | 1 | 2022 | 895 | 0.040 |
Why?
|
K562 Cells | 1 | 2019 | 635 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2006 | 3921 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39052 | 0.040 |
Why?
|
Frameshift Mutation | 1 | 2019 | 399 | 0.040 |
Why?
|
Granulocyte Precursor Cells | 1 | 2016 | 43 | 0.040 |
Why?
|
Lymphocyte Activation | 2 | 2004 | 5524 | 0.030 |
Why?
|
Inhibitory Concentration 50 | 1 | 2016 | 459 | 0.030 |
Why?
|
Prospective Studies | 2 | 2023 | 53290 | 0.030 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2019 | 651 | 0.030 |
Why?
|
Cell Cycle | 1 | 2023 | 2967 | 0.030 |
Why?
|
Erythroid Precursor Cells | 1 | 2016 | 218 | 0.030 |
Why?
|
Pyridoxal Phosphate | 1 | 2015 | 127 | 0.030 |
Why?
|
Etoposide | 1 | 2016 | 641 | 0.030 |
Why?
|
Models, Molecular | 2 | 2015 | 5451 | 0.030 |
Why?
|
Genes, X-Linked | 1 | 2015 | 128 | 0.030 |
Why?
|
Reticulocytes | 1 | 2015 | 290 | 0.030 |
Why?
|
Homeostasis | 1 | 2005 | 3339 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2016 | 730 | 0.030 |
Why?
|
Killer Cells, Natural | 1 | 2022 | 2133 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14723 | 0.030 |
Why?
|
Pregnancy Complications, Hematologic | 1 | 2015 | 183 | 0.030 |
Why?
|
Monoclonal Gammopathy of Undetermined Significance | 1 | 2015 | 177 | 0.030 |
Why?
|
Iron Overload | 1 | 2015 | 242 | 0.030 |
Why?
|
X Chromosome Inactivation | 1 | 2015 | 224 | 0.030 |
Why?
|
Enhancer Elements, Genetic | 1 | 2019 | 1340 | 0.030 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2016 | 624 | 0.030 |
Why?
|
Puerperal Disorders | 1 | 2015 | 275 | 0.030 |
Why?
|
Megakaryocytes | 1 | 2016 | 545 | 0.030 |
Why?
|
Molecular Sequence Data | 2 | 2015 | 18111 | 0.030 |
Why?
|
GATA6 Transcription Factor | 1 | 2011 | 50 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2016 | 2505 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2021 | 15520 | 0.020 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2019 | 1581 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2023 | 3666 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2002 | 4424 | 0.020 |
Why?
|
Stroke Volume | 1 | 2023 | 5006 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2001 | 2725 | 0.020 |
Why?
|
Peptides | 1 | 2022 | 4410 | 0.020 |
Why?
|
Congresses as Topic | 1 | 2014 | 764 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2016 | 1970 | 0.020 |
Why?
|
Models, Biological | 1 | 2006 | 9584 | 0.020 |
Why?
|
Genetic Testing | 1 | 2022 | 3444 | 0.020 |
Why?
|
RNA, Messenger | 2 | 2015 | 13035 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2016 | 2649 | 0.020 |
Why?
|
Chromosome Aberrations | 1 | 2016 | 1813 | 0.020 |
Why?
|
Luciferases | 1 | 2011 | 733 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2019 | 2418 | 0.020 |
Why?
|
Mice, Inbred BALB C | 3 | 2004 | 6386 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2016 | 2204 | 0.020 |
Why?
|
HeLa Cells | 1 | 2015 | 3130 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2006 | 12073 | 0.020 |
Why?
|
Precancerous Conditions | 1 | 2015 | 975 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2016 | 1941 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2015 | 3848 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2019 | 5867 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4751 | 0.020 |
Why?
|
Pedigree | 1 | 2015 | 4642 | 0.020 |
Why?
|
Protein Conformation | 1 | 2015 | 4010 | 0.020 |
Why?
|
Immunophenotyping | 2 | 2001 | 1880 | 0.020 |
Why?
|
Bone Marrow Transplantation | 1 | 2015 | 2765 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2019 | 9735 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2022 | 5534 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2016 | 2182 | 0.020 |
Why?
|
Receptors, Tumor Necrosis Factor, Member 14 | 1 | 2004 | 12 | 0.020 |
Why?
|
Mitochondrial Proteins | 2 | 2001 | 994 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2002 | 7882 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2015 | 6621 | 0.020 |
Why?
|
Incidence | 1 | 2023 | 20952 | 0.020 |
Why?
|
Neovascularization, Physiologic | 1 | 2011 | 1351 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2016 | 2962 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2011 | 2700 | 0.010 |
Why?
|
Mitochondria | 1 | 2016 | 3514 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2024 | 11525 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2019 | 9445 | 0.010 |
Why?
|
Cell Lineage | 2 | 2001 | 2504 | 0.010 |
Why?
|
Protein Binding | 1 | 2015 | 9384 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2016 | 11366 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2020 | 9240 | 0.010 |
Why?
|
Receptors, Interleukin-7 | 1 | 2001 | 38 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2016 | 5172 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2021 | 63107 | 0.010 |
Why?
|
Bromodeoxyuridine | 1 | 2001 | 322 | 0.010 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2002 | 298 | 0.010 |
Why?
|
bcl-X Protein | 1 | 2002 | 411 | 0.010 |
Why?
|
Risk Factors | 2 | 2019 | 72296 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2016 | 16690 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2015 | 57776 | 0.010 |
Why?
|
src-Family Kinases | 1 | 2001 | 551 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2015 | 10483 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2019 | 25628 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2016 | 19905 | 0.010 |
Why?
|
Age Factors | 1 | 2014 | 18373 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 40559 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2016 | 18034 | 0.010 |
Why?
|
Adjuvants, Immunologic | 1 | 2002 | 1000 | 0.010 |
Why?
|
Immunoglobulin M | 1 | 2001 | 1537 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2002 | 3144 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2002 | 1434 | 0.010 |
Why?
|
Pregnancy | 1 | 2015 | 29144 | 0.010 |
Why?
|
Up-Regulation | 1 | 2002 | 4222 | 0.010 |
Why?
|
Cell Line | 1 | 2004 | 16000 | 0.010 |
Why?
|
Aging | 1 | 2001 | 8664 | 0.000 |
Why?
|